-transparent.png){kind=logo}
Pimozide 2-12 mg (median 4 mg) was tried for ten weeks in 44 pseudo-neurotic patients. Unsuccessfully used tranquillizers were continued and the use of the antiparkinsonian agent dexetimide was allowed if needed. By the end of the study, a considerable improvement was observed for the vast majority of the items of the Wittenborn psychiatric scale. Their socio-professional adaptation showed a similar tendency. Dexetimide was required in four patients who received high doses of pimozide.
Related Publications
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
October 1971,
Drug and therapeutics bulletin,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
January 1982,
Acta dermato-venereologica,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
August 1980,
Ugeskrift for laeger,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
January 1971,
Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
January 1982,
Therapia Hungarica (English edition),
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
December 1974,
Acta psiquiatrica y psicologica de America latina,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
January 1980,
Acta psychiatrica Belgica,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
November 1974,
Acta psychiatrica Belgica,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
April 1995,
Revue medicale de Liege,
A J Tanghe, and
A J Boom, and
P Leuridan, and
L Jonckheere, and
F Bruynooghe
January 1973,
Psychiatria, neurologia, neurochirurgia,
